Profil
Birgit M.
Schoeberl worked as a Director at Silver Creek Pharmaceuticals, Inc. and as the Head-Discovery at Merrimack Pharmaceuticals, Inc. She obtained an undergraduate degree from the University of Karlsruhe.
Anciens postes connus de Birgit M. Schoeberl
| Sociétés | Poste | Fin |
|---|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Corporate Officer/Principal | 24/02/2017 |
Silver Creek Pharmaceuticals, Inc.
 Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Directeur/Membre du Conseil | - |
Formation de Birgit M. Schoeberl
| University of Karlsruhe | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Silver Creek Pharmaceuticals, Inc.
Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Health Technology |